Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK EUR

Azelis Group NV (AZEB.XC)

16.44
0.00
(0.00%)
At close: April 1 at 4:16:20 PM GMT+1
Loading Chart for AZEB.XC
  • Previous Close 16.44
  • Open 16.44
  • Bid --
  • Ask 15.10 x --
  • Day's Range 16.44 - 16.44
  • 52 Week Range 16.26 - 22.01
  • Volume 674
  • Avg. Volume 53
  • Market Cap (intraday) 4.002B
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) 22.22
  • EPS (TTM) 0.74
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield 0.23 (1.40%)
  • Ex-Dividend Date Jun 27, 2025
  • 1y Target Est --

Azelis Group NV engages in the distribution and sale of specialty chemicals and food ingredients. The company sells specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, flavours and fragrances, and agricultural environmental solutions; and industrial chemicals industry, such as CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

www.azelis.com

4,321

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AZEB.XC

View More

Performance Overview: AZEB.XC

Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

AZEB.XC
10.19%
BEL 20 (^BFX)
6.89%

1-Year Return

AZEB.XC
24.44%
BEL 20 (^BFX)
15.43%

3-Year Return

AZEB.XC
32.12%
BEL 20 (^BFX)
10.25%

5-Year Return

AZEB.XC
39.23%
BEL 20 (^BFX)
50.26%

Compare To: AZEB.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AZEB.XC

View More

Valuation Measures

Annual
As of 5/2/2025
  • Market Cap

    3.33B

  • Enterprise Value

    4.87B

  • Trailing P/E

    22.22

  • Forward P/E

    18.05

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.95

  • Price/Book (mrq)

    1.39

  • Enterprise Value/Revenue

    1.15

  • Enterprise Value/EBITDA

    10.20

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.29%

  • Return on Assets (ttm)

    4.29%

  • Return on Equity (ttm)

    6.77%

  • Revenue (ttm)

    4.21B

  • Net Income Avi to Common (ttm)

    180.69M

  • Diluted EPS (ttm)

    0.74

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    303.94M

  • Total Debt/Equity (mrq)

    63.15%

  • Levered Free Cash Flow (ttm)

    18.54M

Research Analysis: AZEB.XC

View More

Company Insights: AZEB.XC

Research Reports: AZEB.XC

View More